141 related articles for article (PubMed ID: 7889204)
21. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.
Lafayette RA; Mayer G; Park SK; Meyer TW
J Clin Invest; 1992 Sep; 90(3):766-71. PubMed ID: 1522231
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin blockade prevents salt-induced injury of the renal circulation in spontaneously hypertensive rats.
Susic D; Zhou X; Frohlich ED
Am J Nephrol; 2009; 29(6):639-45. PubMed ID: 19155618
[TBL] [Abstract][Full Text] [Related]
23. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
24. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
25. The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats.
Nagisa Y; Shintani A; Nakagawa S
Diabetologia; 2001 Jul; 44(7):883-8. PubMed ID: 11508274
[TBL] [Abstract][Full Text] [Related]
26. Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.
Noda M; Matsuo T; Fukuda R; Ohta M; Nagano H; Shibouta Y; Naka T; Nishikawa K; Imura Y
Kidney Int; 1999 Sep; 56(3):898-909. PubMed ID: 10469358
[TBL] [Abstract][Full Text] [Related]
27. Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension.
Kawabata M; Takabatake T; Ohta H; Nakamura S; Hara H; Ohta K; Takakuwa H; Han WH; Kobayashi K
Blood Press Suppl; 1994; 5():117-21. PubMed ID: 7889193
[TBL] [Abstract][Full Text] [Related]
28. Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats.
Ideishi M; Miura S; Sakai T; Maeda H; Kinoshita A; Sasaguri M; Jimi S; Arakawa K
Blood Press Suppl; 1994; 5():99-104. PubMed ID: 7889212
[TBL] [Abstract][Full Text] [Related]
29. Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
Otsuka F; Ogura T; Yamauchi T; Sato M; Kataoka H; Kageyama J; Makino H
Kidney Blood Press Res; 2000; 23(1):35-41. PubMed ID: 10567852
[TBL] [Abstract][Full Text] [Related]
30. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
31. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
Katsumata H; Suzuki H; Ohishi A; Nakamoto H; Saruta T; Sakaguchi H
Lab Invest; 1990 Apr; 62(4):474-80. PubMed ID: 2185377
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat.
Kohara K; Mikami H; Okuda N; Higaki J; Ogihara T
Hypertension; 1993 Jun; 21(6 Pt 2):975-9. PubMed ID: 8505110
[TBL] [Abstract][Full Text] [Related]
33. Pilot study of a new angiotensin II receptor antagonist, TCV-116: effects of a single oral dose on blood pressure in patients with essential hypertension.
Ogihara T; Higashimori K; Masuo K; Mikami H
Clin Ther; 1993; 15(4):684-91. PubMed ID: 8221818
[TBL] [Abstract][Full Text] [Related]
34. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
35. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
37. Comparison of converting enzyme inhibitor and calcium channel blocker in SHR with nephrotoxic serum nephritis.
Ohno A; Inagaki C; Honda K; Sugino N
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):405-10. PubMed ID: 1635285
[TBL] [Abstract][Full Text] [Related]
38. [Prevention of hypertensive renal damage by prepubertal treatment with ARB].
Sasamura H
Nihon Rinsho; 2002 Oct; 60(10):1962-7. PubMed ID: 12397692
[TBL] [Abstract][Full Text] [Related]
39. Contribution of renal angiotensin II type I receptor to gene expressions in hypertension-induced renal injury.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Kidney Int; 1994 Nov; 46(5):1346-58. PubMed ID: 7853793
[TBL] [Abstract][Full Text] [Related]
40. [Effects of CS-866, an angiotensin II receptor antagonist, in 5/6 nephrectomized spontaneously hypertensive rats].
Xu HL; Yoshida K; Wu XM; Kohzuki M
Nihon Jinzo Gakkai Shi; 2001 Oct; 43(7):580-8. PubMed ID: 11725555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
